ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Aurora, CO, USA:

ALPINE: Maintenance Letrozole/Abemaciclib

mismatch repair proficient, tumor protein p53 (TP53) wild-type endometrial cancer.The names of the study drugs involved in this stu...

Enrolling
Endometrial Cancer
Recurrent Endometrial Cancer
Drug: Abemaciclib
Drug: Letrozole

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Aurora, Colorado, United States and 7 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Aurora, Colorado, United States and 201 other locations

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...

Enrolling
Endometrial Cancer
Drug: Doxorubicin
Drug: Docetaxel

Phase 3

BioNTech
BioNTech

Aurora, Colorado, United States and 205 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Aurora, Colorado, United States and 188 other locations

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endometrial Cancer
Biological: vudalimab

Phase 2

Xencor
Xencor

Aurora, Colorado, United States and 16 other locations

to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 2

Acrivon Therapeutics

Aurora, Colorado, United States and 89 other locations

Solid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic ch...

Active, not recruiting
Endometrial Cancer
Colon Cancer
Drug: GSK4418959
Biological: PD-1 inhibitor

Phase 1, Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Denver, Colorado, United States and 21 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.

Active, not recruiting
Metastatic Cancer
Endometrial Cancer
Drug: ALTA2618

Phase 1

Alterome Therapeutics, Inc.

Denver, Colorado, United States and 30 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: Bevacizumab
Drug: Pembrolizumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Aurora, Colorado, United States and 59 other locations

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Active, not recruiting
Endometrial Cancer
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Drug: Pembrolizumab
Drug: IDE-161

Phase 1

Ideaya Biosciences

Denver, Colorado, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems